Approximately 20 percent of patients with ATC have a history of differentiated thyroid cancer.

**Cytogenetics**

The cytogenetics are often complex and show progressive accumulation of chromosomal alterations (numerical and structural aberrations). The following gene mutation is commonly reported in ATC: p53 (most common), RAS, BRAF, β-catenin, PIK3CA, Axin, APC, and PTEN.